Floyd R. Sallee, MD, PhD
- 2Articles
- 12.8KReads1
- 2008–2021Active
- 12Collaborators
- 6Citations2
About
Floyd R. Sallee, MD, PhD, is affiliated with Ironshore Pharmaceuticals Inc. in Durham, North Carolina. His publications focus on neurodevelopmental disorders, specifically child and adolescent psychiatry, with studies on treatments for attention-deficit/hyperactivity disorder (ADHD) in pediatric populations. His work includes clinical trials evaluating methylphenidate formulations for symptom management and functional outcomes. Sallee has collaborated frequently with co-authors such as Andrew J. Cutler and L. Eugene Arnold.
Publications
Response and Remission with DR/ER-MPH
June 22, 2021
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
